Tempus AI is trading 4.9% lower at $66.92; no clear company-specific announcement or catalyst explaining the October 8 decline surfaced in available coverage.

  • The October 7 Moderna–Merck collaboration news does not directly explain the drop.
  • Broader markets are under pressure amid rising Treasury yields, higher oil prices, and renewed inflation and geopolitical concerns. These conditions may be contributing to weakness, though the provided market-index moves are below the 0.5% threshold for a strong same-direction market explanation.